Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/12 → 31/12/14 |
Funding
- NHMRC National Health and Medical Research Council
Research output
- 3 Article
-
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid with IQ and Bronchopulmonary Dysplasia in Children Born Preterm
Sullivan, T. R., Gould, J. F., Bednarz, J. M., McPhee, A. J., Gibson, R., Anderson, P. J., Best, K. P., Sharp, M., Cheong, J. L. Y., Opie, G. F., Travadi, J., Davis, P. G., Simmer, K., Collins, C. T., Doyle, L. W. & Makrides, M., 9 Jun 2023, In: JAMA Network Open. 6, 6, p. E2317870Research output: Contribution to journal › Article › peer-review
Open Access11 Link opens in a new tab Citations (Web of Science) -
Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): A follow-up of a randomised controlled trial
Gould, J. F., Makrides, M., Sullivan, T. R., Anderson, P. J., Gibson, R. A., Best, K. P., McPhee, A. J., Doyle, L. W., Opie, G., Travadi, J., Cheong, J., Davis, P. G., Sharp, M., Simmer, K. & Collins, C. T., 5 Feb 2021, In: BMJ Open. 11, 2, 041597.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Citations (Scopus) -
The N3RO trial: A randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants <29 weeks' gestation
Collins, C. T., Gibson, R. A., Makrides, M., Mcphee, A. J., Sullivan, T. R., Davis, P. G., Thio, M., Simmer, K., Rajadurai, V. S., Ryan, P., Morris, S., Stark, M., Travadi, J., Wright, I., Tan, K., Holberton, J., Opie, G., Callander, I., Stack, J. & Shein, D. & 8 others, , 1 Jun 2016, In: BMC Pediatrics. 16, 1, p. Article 72 72.Research output: Contribution to journal › Article › peer-review
Open Access27 Link opens in a new tab Citations (Scopus)